Balance Sheet Data

Teva Pharmaceutical Industries Limi... (TEVA)

$8.7

-0.07 (-0.80%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 9631,7821,9752,1772,1651,522.761,400.021,287.191,183.441,088.06
Total Cash (%)
Account Receivables 7,1285,8225,6764,5814,5294,448.554,0903,760.363,457.283,178.63
Account Receivables (%)
Inventories 4,9244,7314,4224,4033,8183,613.343,322.123,054.362,808.182,581.85
Inventories (%)
Accounts Payable 2,0691,8531,7181,7561,6861,471.711,353.091,244.031,143.771,051.58
Accounts Payable (%)
Capital Expenditure -874-651-525-578-562-510.25-469.12-431.31-396.55-364.59
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.